Dr Ryan Toh
Dr Ryan Toh
Details
Role
Senior Research Officer
Research area
Infection, Immunity and Global Health
Group
Vaccine Immunology
Dr Ryan Toh completed his PhD in the Department of Paediatrics at the University of Melbourne in 2017. He started his role as a Research Officer in the New Vaccines Research Group in 2018 under the supervision of Professor Kim Mulholland and Associate Professor Paul Licciardi.
Ryan's research interests include exploring alternative human papillomavirus (HPV) vaccination strategies such as reduced-dose schedule and targeted vaccination of high-risk groups, to improve vaccine uptake in resource-limited settings. He has been involved in several vaccine clinical trials and has acquired considerable experience in several microbiological and immunological techniques. He has presented at numerous scientific meetings and published more than 40 manuscripts and book chapters.
Ryan's research interests include exploring alternative human papillomavirus (HPV) vaccination strategies such as reduced-dose schedule and targeted vaccination of high-risk groups, to improve vaccine uptake in resource-limited settings. He has been involved in several vaccine clinical trials and has acquired considerable experience in several microbiological and immunological techniques. He has presented at numerous scientific meetings and published more than 40 manuscripts and book chapters.
Dr Ryan Toh completed his PhD in the Department of Paediatrics at the University of Melbourne in 2017. He started his role as a Research Officer in the New Vaccines Research Group in 2018 under the supervision of Professor Kim Mulholland and Associate...
Dr Ryan Toh completed his PhD in the Department of Paediatrics at the University of Melbourne in 2017. He started his role as a Research Officer in the New Vaccines Research Group in 2018 under the supervision of Professor Kim Mulholland and Associate Professor Paul Licciardi.
Ryan's research interests include exploring alternative human papillomavirus (HPV) vaccination strategies such as reduced-dose schedule and targeted vaccination of high-risk groups, to improve vaccine uptake in resource-limited settings. He has been involved in several vaccine clinical trials and has acquired considerable experience in several microbiological and immunological techniques. He has presented at numerous scientific meetings and published more than 40 manuscripts and book chapters.
Ryan's research interests include exploring alternative human papillomavirus (HPV) vaccination strategies such as reduced-dose schedule and targeted vaccination of high-risk groups, to improve vaccine uptake in resource-limited settings. He has been involved in several vaccine clinical trials and has acquired considerable experience in several microbiological and immunological techniques. He has presented at numerous scientific meetings and published more than 40 manuscripts and book chapters.
Top Publications
- Toh, ZQ, Anzela, A, Tang, MLK, Licciardi, PV. Probiotic Therapy as a Novel Approach for Allergic Disease. Frontiers in Pharmacology 3: 171 2024 view publication
- Hoe, E, Boelsen, LK, Toh, ZQ, Sun, GW, Koo, GC, Balloch, A, Marimla, R, Dunne, EM, Tikoduadua, L, Russell, FM, et al. Reduced IL-17A Secretion Is Associated with High Levels of Pneumococcal Nasopharyngeal Carriage in Fijian Children. PLOS ONE 10(6) : e0129199 2024 view publication
- Hoe, E, Nathanielsz, J, Toh, ZQ, Spry, L, Marimla, R, Balloch, A, Mulholland, K, Licciardi, PV. Anti-Inflammatory Effects of Vitamin D on Human Immune Cells in the Context of Bacterial Infection. Nutrients 8(12) : 806 2024 view publication
- Dunne, EM, Toh, ZQ, John, M, Manning, J, Satzke, C, Licciardi, P. Investigating the effects of probiotics on pneumococcal colonization using an in vitro adherence assay.. Journal of Visualized Experiments 2024 view publication
- Toh, ZQ, Kosasih, J, Russell, FM, Reyburn, R, Fong, J, Tuivaga, E, Ratu, FT, Nguyen, CD, Matanitobua, S, Ha, LA, et al. Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules. Vaccines 7(4) : 200 2024 view publication
Page 1 of 15
Career information
Share //
